
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing azithromycin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing azithromycin are listed in tablet, powder for suspension, injection, suspension and solution forms. No finished azithromycin product of any kind is listed in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Azithromycin is a macrolide antibiotic, given by mouth, by injection or as eye drops, that a pharmacy may compound when a prescriber orders it.
Azithromycin is a macrolide antibiotic derived from erythromycin. It binds the 50S subunit of the bacterial ribosome and blocks protein synthesis, which mainly stops bacteria from growing. It moves readily into tissues and cells, which suits it to bacteria that live inside cells. Manufactured products include Zithromax tablets and oral suspension and many generics, indicated for certain mild to moderate infections such as community-acquired pneumonia, acute bacterial sinusitis, pharyngitis or tonsillitis, skin infections, urethritis and cervicitis, chancroid in men, and acute otitis media in children; Zithromax intravenous injection, indicated for community-acquired pneumonia and pelvic inflammatory disease in adults; and AzaSite eye drops, indicated for bacterial conjunctivitis. A prescriber might order azithromycin compounded in a strength, flavor or form that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Azithromycin labels carry no boxed warning. Do not use it if you are allergic to azithromycin, erythromycin or any macrolide or ketolide, or if you had jaundice or liver problems with past azithromycin use. Serious, sometimes fatal, allergic and skin reactions and liver injury have been reported; stop and get help for rash, blistering, facial swelling, yellow skin or eyes, or dark urine. It can prolong the QT interval and cause a dangerous heart rhythm, so tell your prescriber about QT problems, low potassium or magnesium, an irregular heartbeat, or other drugs that affect heart rhythm. Some studies suggest a higher short-term risk of cardiovascular death. Severe diarrhea from C. difficile can occur up to two months or more later. It may worsen myasthenia gravis. In babies under 6 weeks, report vomiting or irritability with feeding (pyloric stenosis). It may raise warfarin's effect. The label says not to take aluminum or magnesium antacids at the same time as azithromycin, and MedlinePlus advises spacing them. Pregnancy data have not shown a drug-associated risk of birth defects. LactMed says it is not expected to harm a breastfed infant; watch for diarrhea, vomiting or rash. Talk to your prescriber or pharmacist about side effects.
Azithromycin is a macrolide derived from erythromycin, with a methyl-substituted nitrogen in its lactone ring (label), that binds the 23S portion of the 50S ribosomal subunit; it is mainly bacteriostatic, though at higher doses it is bactericidal against some organisms such as streptococci and H. influenzae, and it has immunomodulatory effects (StatPearls). Per the Zithromax oral label, absolute bioavailability is 38 percent; food raises peak levels of the suspension but not AUC; serum protein binding falls from 51 to 7 percent as concentration rises; tissue penetration is extensive; terminal half-life is about 68 hours; and biliary excretion of unchanged drug is a major route, with about 6 percent in urine over a week. Labeled indications: the oral infections above (Zithromax tablets and oral suspension, NDA); community-acquired pneumonia and pelvic inflammatory disease (Zithromax intravenous, NDA); bacterial conjunctivitis (AzaSite ophthalmic solution, NDA). StatPearls lists off-label uses including enteric fever and bronchiolitis obliterans prophylaxis after lung transplant, and notes long-term use in cystic fibrosis with Pseudomonas; these are not FDA-approved indications. Contraindications: macrolide or ketolide hypersensitivity, and prior azithromycin-associated cholestatic jaundice. Monitor with nelfinavir, warfarin, digoxin, colchicine and phenytoin. StatPearls advises against long-term prophylaxis after hematopoietic stem cell transplant. Not a controlled substance. Dosing is per prescriber.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth